MultiSensor AI (MSAI) director-linked 325 Capital reports grants, large warrant stakes
Rhea-AI Filing Summary
MultiSensor AI Holdings, Inc. reported updated holdings for investment entities affiliated with 325 Capital and director designee Daniel M. Friedberg. Friedberg was granted 3,738 shares of common stock at $0.0000 per share as a director award, increasing his direct holdings to 9,872 shares, which he holds on behalf of 325 or its affiliates under a pre-existing arrangement.
Indirectly, 325 Capital LLC is shown with 543,697 common shares and warrants linked to 1,881,339 underlying shares, while 325 Capital Master Fund LP is shown with 121,081 common shares and warrants linked to 459,797 underlying shares, all at an exercise price of $5.98 per share. The warrants are exercisable from the date of stockholder approval for five years and are subject to a 49.5% Maximum Ownership Limitation, with a mechanism to receive Series A convertible preferred stock instead of common stock if the cap would be exceeded.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common stock, $0.0001 par value per share | 3,738 | $0.00 | -- |
| holding | Warrants to purchase common stock | -- | -- | -- |
| holding | Warrants to purchase common stock | -- | -- | -- |
| holding | Common stock, $0.0001 par value per share | -- | -- | -- |
| holding | Common stock, $0.0001 par value per share | -- | -- | -- |
Footnotes (1)
- This Form 4 is being filed jointly by 325 Capital Master Fund LP, a Cayman Islands exempted limited partnership ("325 Master Fund"), 325 Capital GP, LLC, a Delaware limited liability company registered as a foreign partnership in the Cayman Islands ("325 Capital GP"), 325 Capital LLC, a Delaware limited liability company ("325"), Michael Braner, a United States citizen, Daniel Friedberg, a United States citizen, and Anil Shrivastava, a United States citizen (collectively, the "Reporting Persons"). Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Reflects the Issuer's 1-for-40 reverse stock split, effective April 13, 2026. Mr. Friedberg serves as a director designee of 325 on the Board of Directors of the Issuer. In connection with this arrangement, any equity-based securities awarded to Mr. Friedberg in his capacity as a director of the Issuer will be held by Mr. Friedberg on behalf of 325 or its affiliates, transferred by Mr. Friedberg to 325 or its affiliates, and/or sold by Mr. Friedberg, with the proceeds of such sale to be remitted to 325 or its affiliates, in each case as directed by 325. Accordingly, Mr. Friedberg does not have a direct pecuniary interest in these securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), however, 325 and Messrs. Braner, Friedberg and Shrivastava may be deemed to have a pecuninary interest in these securities for purposes of Section 16 of the Exchange Act pursuant to the foregoing sentence. Securities owned directly by 325 Master Fund. 325 Capital GP is the general partner of 325 Master Fund, 325 is the investment manager to 325 Master Fund, and each of Messrs. Braner, Friedberg and Shrivastava are Managing Members of 325. As a result of these relationships, all of the Reporting Persons may be deemed to beneficially own the securities owned directly by 325 Master Fund. Securities owned directly by certain separately managed accounts ("SMAs") that are deemed beneficially owned by 325 as a result of 325 serving as the investment manager to such SMAs. Each of Messrs. Braner, Friedberg and Shrivastava are Managing Members of 325. As a result of these relationships, they may be deemed to beneficially own the securities beneficially owned by 325. The Warrants are exercisable from the date of the Stockholder Approval and expire five years from the date of issuance. The SPA and the Warrants provide that each Warrant holder's beneficial ownership of shares, including after taking into account the full exercise of such holder's Warrant, shall in no event exceed 49.5% of the issued and outstanding shares (the "Maximum Ownership Limitation"). Pursuant to the Warrants, in the event that a holder's Warrant is not exercisable for shares due to the beneficial ownership of such holder exceeding the Maximum Ownership Limitation, the applicable Warrant will be exercisable for shares of the Issuer's Series A Convertible Preferred Stock, par value $0.0001 per share, that are convertible into an equivalent number of shares for which the Warrant is exercisable.